International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
By Maria P. Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, Eric A. Barnard, Jose L. Boyer, Charles Kennedy, G. Knight, M. Fumagalli, Christian Gachet, K. Jacobson and 1 more. Pharmacological Reviews, 2006
1,258 citations recorded by the source corpus.
Subfields: Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/a91aca73f69784d5444a6805f02a1f5af7d4416d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Physiology
- H. Hammad
- Angelika Schmidt
- P. Krammer
- G. Burnstock
- Nina Oberle
- W. Junger
- Guo-Yuan Yang
- Yongting Wang
Citations in the corpus
- Purinergic signalling and disorders of the central nervous system (2008, background): “Currently, 4 subtypes of P1 receptor, 7 subtypes of ionotropic P2X receptors, many of which can form heteromultimers and homomultimers, and 8 subtypes of metabotropic P2Y receptors are known to exis”
- Physiology of Astroglia. (2018, neutral): “Developmental expression of metabotropic P2Y(1) and P2Y(2) receptors in freshly isolated astrocytes from rat hippocampus.”
- Molecular Mechanisms of Treg-Mediated T Cell Suppression (2012, background): “In human but not mouse T cells, ATP can also directly increase cAMP levels through the P2Y 11 receptor (Abbracchio et al., 2006).”
- Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells (2007, background): “P2R inhibition reduces airway inflammation Suramin, a broad-range inhibitor of P2R”